Evidence map›Paper›PMID 33897337›Full record

ArticleJournal of Taibah University Medical Sciences2021

Postpartum prophylaxis of venous thromboembolism with anticoagulation: A case report.

Yahya A Mohzari, Syed M B Asdaq, Reem F Bamogaddam, Khlood Alattas, Sami Asalmi, Renad A Alshuraim

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of Taibah University Medical Sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Yahya A MohzariDepartment of Clinical Pharmacy, King Saud Medical City, Riyadh, KSA.
Syed M B AsdaqDepartment of Pharmacology and Therapeutics, College of Pharmacy, AlMaarefa University, Riyadh, KSA.
Reem F BamogaddamDepartment of Pharmacy, Novartis Company, Riyadh, KSA.
Khlood AlattasDepartment of Pharmacy, Novartis Company, Riyadh, KSA.
Sami AsalmiDepartment of Clinical Pharmacy, King Saud Medical City, Riyadh, KSA.
Renad A AlshuraimDepartment of Clinical Pharmacy, King Saud Medical City, Riyadh, KSA.
King Saud Medical City · SANovartis (Switzerland) · CHCentral Asian University · UZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although there is a remarkably high risk of venous thromboembolism (VTE) during pregnancy and postpartum, a cautious approach is needed while initiating therapeutic and prophylactic anticoagulant therapy. The merits of heparin for thromboprophylaxis in postpartum patients are exaggerated, and its risk is generally overlooked. This study aimed to report the inappropriate use of anticoagulants in postpartum patients. The patient in this report was a 31-year-old healthy woman who had had a normal spontaneous vaginal delivery and visited the hospital a 3-day history of small itchy blisters at the enoxaparin injection sites. An examination revealed class II obesity. The Naranjo Scale assessment showed the possibility of an enoxaparin-induced hypersensitivity reaction. The clinical care team decided to discontinue the heparin. A follow-up examination did not show any signs of VTE. Although many pregnant and postnatal women might need VTE prophylaxis, routine anticoagulation for such a population is not essential. Clinicians should weigh the risks versus benefits to avoid any adverse drug reactions that may occur with this class of medication.

Indexed as

AnticoagulantPostpartumProphylaxisRisk assessmentRiyadh

Identifiers

PMID33897337
PMCPMC8046954
OpenAlexW3124939481

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.